Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 22, 2023
September 22, 2023
3344b1c7-a603-4d25-a0d9-fa9de797e2e7
Related Documents
Labeling for Biosimilar and Interchangeable Biosimilar Products
Guidance DocumentSeptember 18, 2023Center for Drug Evaluation and Research
Risk Management Plans to Mitigate the Potential for Drug Shortages
Guidance DocumentMay 19, 2022Center for Drug Evaluation and Research
Fabry Disease: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 7, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox